Breakthrough trial aims to cure childhood cancer with fewer side effects
NCT ID NCT03020030
Summary
This study is testing a more personalized approach to treating children and young adults with acute lymphoblastic leukemia (ALL), the most common childhood cancer. Researchers are using updated risk factors to determine treatment intensity and testing a new way to dose a key chemotherapy drug based on blood levels. The goal is to improve cure rates while reducing side effects by giving stronger treatment only to those who need it and adjusting medication doses based on individual responses.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA, PEDIATRIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Centre Hospitalier U. de Quebec
Québec, Quebec, Canada
-
Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian
New York, New York, 10032, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Hasbro Children's Hospital / Rhode Island Hospital
Providence, Rhode Island, 02903, United States
-
Hospital Sainte Justine, University of Montreal
Montreal, Quebec, Canada
-
Montefiore Medical Center
The Bronx, New York, 10467, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
Conditions
Explore the condition pages connected to this study.